See more : Emerson Electric Co. (EMR.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Petros Pharmaceuticals, Inc. (PTPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Petros Pharmaceuticals, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Electreon Wireless Ltd (ELWS.TA) Income Statement Analysis – Financial Results
- Workspace Group plc (WKP.L) Income Statement Analysis – Financial Results
- Brimag Digital Age Ltd. (BRMG.TA) Income Statement Analysis – Financial Results
- Investview, Inc. (INVUP) Income Statement Analysis – Financial Results
- Rooshine, Inc. (RSAU) Income Statement Analysis – Financial Results
Petros Pharmaceuticals, Inc. (PTPI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.petrospharma.com
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 5.82M | 5.99M | 7.81M | 9.56M | 15.58M | 14.05M |
Cost of Revenue | 1.63M | 2.29M | 1.60M | 4.05M | 7.43M | 10.48M |
Gross Profit | 4.19M | 3.70M | 6.21M | 5.51M | 8.15M | 3.57M |
Gross Profit Ratio | 71.98% | 61.79% | 79.52% | 57.67% | 52.32% | 25.41% |
Research & Development | 2.41M | 1.74M | 1.79M | 459.64K | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.26M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -41.15K |
SG&A | 9.26M | 12.21M | 15.59M | 15.67M | 19.73M | 11.22M |
Other Expenses | 6.14M | 5.60M | 6.88M | 6.66M | 5.29M | 0.00 |
Operating Expenses | 17.81M | 19.55M | 24.26M | 22.80M | 25.02M | 11.22M |
Cost & Expenses | 19.44M | 21.84M | 25.86M | 26.84M | 32.45M | 21.70M |
Interest Income | 515.31K | 14.19K | 368.66K | 3.05M | 13.84M | 11.86M |
Interest Expense | 536.14K | 596.02K | 368.66K | 3.05M | 13.84M | 0.00 |
Depreciation & Amortization | 3.42M | 5.72M | 6.98M | 6.75M | 5.32M | 8.06M |
EBITDA | -4.21M | -13.73M | -1.64M | -12.21M | -14.00M | 373.58K |
EBITDA Ratio | -72.34% | -114.20% | -143.00% | -111.11% | -74.32% | 2.95% |
Operating Income | -13.62M | -15.85M | -18.05M | -17.28M | -16.87M | -7.65M |
Operating Income Ratio | -233.88% | -264.45% | -231.05% | -180.78% | -108.29% | -54.45% |
Total Other Income/Expenses | 5.45M | -121.82K | 9.06M | -4.73M | -13.84M | -24.84M |
Income Before Tax | -8.16M | -20.04M | -8.99M | -22.01M | -33.16M | -32.49M |
Income Before Tax Ratio | -140.20% | -334.40% | -115.05% | -230.27% | -212.86% | -231.20% |
Income Tax Expense | 0.00 | 7.00M | 368.66K | -1.43M | -645.87K | -13.37K |
Net Income | -8.16M | -27.04M | -9.36M | -20.59M | -32.51M | -32.47M |
Net Income Ratio | -140.20% | -451.22% | -119.77% | -215.35% | -208.71% | -231.10% |
EPS | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 | -324.73 |
EPS Diluted | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 | -324.73 |
Weighted Avg Shares Out | 2.18M | 2.07M | 1.09M | 970.77K | 170.70K | 100.00K |
Weighted Avg Shares Out (Dil) | 2.18M | 2.07M | 1.09M | 970.77K | 170.70K | 100.00K |
Trending Penny Stocks to Buy Today? 3 For Your Watchlist
5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again
Best Penny Stocks To Buy Now? 3 To Watch Before Next Week
Trending Penny Stocks to Buy For Under $4? Check These 3 Out
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
Biotech Penny Stocks To Buy After BLU Stock Explodes? 3 To Watch
Petros Pharmaceuticals Stock (PTPI): Why The Price Increased Today
Best Penny Stocks to Buy This Coming Week? 3 to Watch
4 Penny Stocks To Buy For Under $5 Before 2022
Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch
Source: https://incomestatements.info
Category: Stock Reports